Cassady Schiller Wealth Management, LLC Amicus Therapeutics, Inc. Transaction History
Cassady Schiller Wealth Management, LLC
- $268 Million
- Q4 2024
A detailed history of Cassady Schiller Wealth Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Cassady Schiller Wealth Management, LLC holds 44 shares of FOLD stock, worth $424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44Holding current value
$424% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
310MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA29.3MShares$282 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$270 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$235 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$231 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$223 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.7B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...